Education
About Us
Working with TipRanks
Follow Us
LifeMD (LFMD)
NASDAQ:LFMD
LFMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.99 - $15.84
Previous CloseN/A
Volume302.38K
Average Volume (3M)1.68M
Market Cap
$479.47M
Enterprise Value$487.90M
Total Cash (Recent Filing)$34.39M
Total Debt (Recent Filing)$25.10M
Price to Earnings (P/E)―
Beta1.62
Next Earnings
Aug 07, 2025EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding45,447,605
10 Day Avg. Volume1,134,619
30 Day Avg. Volume1,677,270
Financial Highlights & Ratios
PEG Ratio-1.14
Price to Book (P/B)-202.46
Price to Sales (P/S)0.00
P/FCF Ratio156.90
Enterprise Value/Market Cap1.02
Enterprise Value/Revenue0.63
Enterprise Value/Gross Profit2.40
Enterprise Value/Ebitda-19.03
Forecast
1Y Price Target
$14.60Price Target Upside38.39% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
LifeMD News
PremiumCompany Announcements
LifeMD Stockholders Approve Directors and Accounting Firm
PremiumCompany Announcements
LifeMD’s Earnings Call: Positive Growth and Strategic ExpansionBulls Say, Bears Say
Bulls Say
Financial PerformancePositive operating cash flows with $34.4M in cash and $3.1M from operating activities indicate financial strength.
Revenue GuidanceManagement has raised total revenue guidance to $268-275M, including Telehealth revenue of $208-213M.
Subscriber GrowthTelehealth active subscriber base grew 22% YoY to 290,660, indicating strong growth momentum.
Bears Say
Conversion ChallengeLFMD must convert its patients from compounded semaglutide to branded alternatives within 90 days, posing a challenge.
FDA Ruling ImpactThe FDA ruling that Novo Nordisk's injectable semaglutide is no longer in shortage led to a significant decline in LFMD shares.
Revenue Growth RisksRisks include lower than projected growth of telehealth revenue, inability to acquire and retain new patients, and higher than expected competition.
Ownership Overview
16.65% Insiders
9.21% Mutual Funds
0.58% Other Institutional Investors
63.79% Public Companies and
Individual Investors
LFMD FAQ
What was LifeMD’s price range in the past 12 months?
LifeMD lowest stock price was $3.99 and its highest was $15.84 in the past 12 months.
What is LifeMD’s market cap?
LifeMD’s market cap is $479.47M.
When is LifeMD’s upcoming earnings report date?
LifeMD’s upcoming earnings report date is Aug 07, 2025 which is in 16 days.
How were LifeMD’s earnings last quarter?
LifeMD released its earnings results on May 06, 2025. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of -$0.053 by $0.063.
Is LifeMD overvalued?
According to Wall Street analysts LifeMD’s price is currently Undervalued.
Does LifeMD pay dividends?
LifeMD does not currently pay dividends.
What is LifeMD’s EPS estimate?
LifeMD’s EPS estimate is >-0.01.
How many shares outstanding does LifeMD have?
LifeMD has 45,447,605 shares outstanding.
What happened to LifeMD’s price movement after its last earnings report?
LifeMD reported an EPS of $0.01 in its last earnings report, beating expectations of -$0.053. Following the earnings report the stock price went up 3.222%.
Which hedge fund is a major shareholder of LifeMD?
Currently, no hedge funds are holding shares in LFMD
LifeMD Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$14.60 (38.39% Upside)
$14.60 (38.39% Upside)
Blogger Sentiment
Bullish
LFMD Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 75.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $4.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.6%
Last 30 Days ▼ 5.1%
Last 30 Days ▼ 5.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
61.06%
12-Months-Change
Fundamentals
Return on Equity
301.60%
Trailing 12-Months
Asset Growth
19.79%
Trailing 12-Months
Company Description
LifeMD
LifeMD, Inc. (LFMD) is a leading direct-to-patient telehealth company that provides a robust end-to-end healthcare platform designed to improve the accessibility and efficiency of healthcare services. The company operates primarily in the telemedicine sector and offers a broad range of services including virtual medical consultations, prescription medications, and wellness products. LifeMD's core services are focused on providing comprehensive healthcare solutions directly to consumers through a seamless, technology-driven experience.
LFMD Company Deck
LFMD Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call for LifeMD reflects a positive sentiment, characterized by strong revenue growth in the Telehealth segment, strategic collaborations, and expansion into new verticals. The company achieved positive GAAP net income for the first time and raised its financial guidance for the year. Despite minor challenges such as a decline in WorkSimpli subscribers and a decrease in gross margin, the company's highlights significantly outweigh the lowlights.Read More>LFMD Stock 12 Month Forecast
Average Price Target
$14.60
▲(38.39%Upside)
Technical Analysis
Orasure Technologies
―
Petmed Express
―
Walgreens Boots Alliance
―
Foghorn Therapeutics
―
Atea Pharmaceuticals
―